Invention Application
- Patent Title: IDENTIFICATION AND USE OF SMALL MOLECULES TO MODULATE TRANSCRIPTION FACTOR FUNCTION AND TO TREAT TRANSCRIPTION FACTOR ASSOCIATED DISEASES
- Patent Title (中): 鉴定和使用小分子调节转录因子功能和治疗转录因子相关疾病
-
Application No.: US12727740Application Date: 2010-03-19
-
Publication No.: US20110071142A1Publication Date: 2011-03-24
- Inventor: Peter Oettgen , Alan C. Rigby , Towia Libermann
- Applicant: Peter Oettgen , Alan C. Rigby , Towia Libermann
- Applicant Address: US MA Boston
- Assignee: BETH ISRAEL DEACONESS MEDICAL CENTER
- Current Assignee: BETH ISRAEL DEACONESS MEDICAL CENTER
- Current Assignee Address: US MA Boston
- Main IPC: C40B30/02
- IPC: C40B30/02 ; A61K31/136 ; A61K31/36 ; A61K31/52 ; A61K31/5415 ; A61K31/167 ; A61K31/17 ; A61K31/428 ; A61K31/225 ; A61K31/37 ; A61K31/443 ; C07D317/58 ; C07D473/38 ; C07D279/16 ; C07C233/29 ; C07C275/40 ; C07C321/26 ; C07D317/68 ; C07D417/12 ; C07C233/33 ; C07C271/28 ; C07D407/06 ; C07D405/12 ; C07D317/66 ; C07C275/38 ; A61P1/00 ; A61P29/00 ; A61P17/06 ; A61P27/02 ; A61P35/00

Abstract:
The present invention relates to methods of identifying small molecule candidate agents capable of modulating transcription factor function such that the function/expression of a target transcription factor and/or proteins downstream of this target protein comprises the screening of small molecule libraries using in silico high throughput docking for candidate small molecules/agents that are selectively identified for their ability to target and disrupt the transcription factor-DNA interface through unique transcription factor and/or DNA descriptors that are defined within a pharmacophore, and then testing/evaluating the candidate agents identified above through one or more in vitro assays for their ability to modulate transcription factor function including expression of this target protein and/or proteins that are downstream of the target transcription factor. The present invention also relates to various compounds described herein (e.g., a compound of Formula XI), their pharmaceutically acceptable salts and to methods of using said compounds as described herein.
Information query